Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR.
Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR.
复制标题
表达小反刍兽疫病毒(PPRV)血凝素的重组腺病毒可保护山羊免受致病病毒的攻击;针对 PPR 的 DIVA 疫苗。
DOI:
10.1186/1297-9716-45-24
复制
发表时间:
2014-02-26
影响因子:
4.4
通讯作者:
Taylor G
中科院分区:
文献类型:
--
作者:
Herbert R;Baron J;Batten C;Baron M;Taylor G
Peste des petits ruminants virus (PPRV) is a morbillivirus that can cause severe disease in sheep and goats, characterised by pyrexia, pneumo-enteritis, and gastritis. The socio-economic burden of the disease is increasing in underdeveloped countries, with poor livestock keepers being affected the most. Current vaccines consist of cell-culture attenuated strains of PPRV, which induce a similar antibody profile to that induced by natural infection. Generation of a vaccine that enables differentiation of infected from vaccinated animals (DIVA) would benefit PPR control and eradication programmes, particularly in the later stages of an eradication campaign and for countries where the disease is not endemic. In order to create a vaccine that would enable infected animals to be distinguished from vaccinated ones (DIVA vaccine), we have evaluated the immunogenicity of recombinant fowlpox (FP) and replication-defective recombinant human adenovirus 5 (Ad), expressing PPRV F and H proteins, in goats. The Ad constructs induced higher levels of virus-specific and neutralising antibodies, and primed greater numbers of CD8+ T cells than the FP-vectored vaccines. Importantly, a single dose of Ad-H, with or without the addition of Ad expressing ovine granulocyte macrophage colony-stimulating factor and/or ovine interleukin-2, not only induced strong antibody and cell-mediated immunity but also completely protected goats against challenge with virulent PPRV, 4 months after vaccination. Replication-defective Ad-H therefore offers the possibility of an effective DIVA vaccine.
登录
查看更多内容
影响因子:
5.1
作者:
Geutskens, SB;van der Eb, MM;Hoeben, RC
通讯作者:
Hoeben, RC
影响因子:
5.5
作者:
JONES, L;GIAVEDONI, L;YILMA, T
通讯作者:
YILMA, T
影响因子:
5
作者:
Abaitua, F;Rodríguez, JR;Esteban, M
通讯作者:
Esteban, M
影响因子:
6.4
作者:
Gans, Hayley A.;Yasukawa, Linda L.;Arvin, Ann M.
通讯作者:
Arvin, Ann M.
影响因子:
2.8
作者:
Alvarez-Lajonchere, Liz;Amador-Canizares, Yalena;Duenas-Carrera, Santiago
通讯作者:
Duenas-Carrera, Santiago